Download PDF
Arzneimittelforschung 2011; 61(11): 605-609
DOI: 10.1055/s-0031-1300562
Phyto-oestrogens
Editio Cantor Verlag Aulendorf (Germany)

Effect of Lactobacillus sporogenes on oral isoflavones bioavailability: single dose pharmacokinetic study in menopausal women

Claudio Benvenuti
1   Medical Department, Rottapharm, Madaus, Monza, Italy
,
Ivo Setnikar
2   Nutraceutical R&D, Rottapharm, Madaus, Monza, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
06 February 2012 (online)

    Permissions and Reprints

Abstract

Purpose of the study

To verify the single dose bioavailability of two oral formulations of soy isoflavones, with and without lactobacilli, in menopausal women in antibiotic therapy.

Methods

Twelve menopause women (mean age 54.3 years, BMI 25.0 kg/m2) participated in a controlled cross-over study. Reference and test treatments were: R = tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3; E = R + 500 million vital spores of Lactobacillus sporogenes (E is Estromineral®, a food supplement containing soy isoflavones 60 mg, calcium 141 mg and vitamin D3 5 µg).

The design included 2 periods of 5 days of amoxicillin + clavulanate treatment with a 2-week wash-out. After each period alternatively a single dose of each formulation was given in randomised sequence. Genistein and daidzein were determined in plasma by HPLC, sampled 10 times within 24 h after dosing.

Results

Genistein pharmacokinetics parameters were higher after E than after R administration: peak plasma concentration (Cmax) +24.3%, area under the concentration curve (AUC0–24) +24.4% and mean residence time +11.0%. Daidzein Cmax and AUC showed a larger variability on R, evidenced by higher scatter from the mean on the formulation without lactobacilli.

Conclusion

A trend is shown for a greater absorption of genistein from a formulation containing lactobacilli.

Key words

Food supplement - Genistein - Isoflavones - Lactobacillus sporogenes - Pharmacokinetics - Phyto-oestrogens
 

  • References

  • 1 Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab. 1998; Dec 12 (4) 605-23
    PubMedGoogle Scholar
  • 2 Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002; 22: 19-34 Epub 2002 fan 4
    CrossrefPubMedGoogle Scholar
  • 3 Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999; Mar 129 (3) 758S-767S
    PubMedGoogle Scholar
  • 4 Nielsen IL, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer. 2007; 57 (1) 1-10
    CrossrefPubMedGoogle Scholar
  • 5 Metzner JE, Frank T, Kunz I, Burger D, Riegger C. Study on the pharmacokinetics of synthetic genistein after multiple oral intake in post-menopausal women. Arzneimittelforschung. 2009; 59 (10) 513-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Anupongsanugool E, Teekachunhatean S, Rojanasthien N, Pongsatha S, Sangdee C. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women. BMC Clin Pharmacol. 2005; 5 (1) 2
    PubMedGoogle Scholar
  • 7 Turner NJ, Thomson BM, Shaw IC. Bioactive isoflavones in functional foods: the importance of gut microflora on bioavailability. Nutr Rev. 2003; 61: 204-13
    CrossrefPubMedGoogle Scholar
  • 8 Rowland I, Faugham M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr. 2003; 89: S45-S58
    PubMedGoogle Scholar
  • 9 Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001; 131 (4 Suppl) 1362S-75S
    PubMedGoogle Scholar
  • 10 Palacios S, Rojo IA, Cancelo MJ, Neyro JL, Castelo-Branco C. Women’s perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol. 2008; 24 (4) 178-83
    CrossrefPubMedGoogle Scholar
  • 11 Caputi AP, Arcoraci V, Benvenuti C. Estronet Study group. Soy isoflavones, lactobacilli, vitamin D3 and calcium: observational study in menopause. Gior It Ost Gin. 2006; XXVIII (3) 212-21
    PubMedGoogle Scholar
  • 12 Mucci M, Carraro C, Mancino P, Monti M, Papadia LS, Volpini G et al. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium: controlled clinical study in menopause. Minerva Ginecol. 2006; Aug 58 (4) 323-34
    PubMedGoogle Scholar
  • 13 Agosta C, Atlante M, Benvenuti C, Estronet Study Group. Randomised controlled study on clinical efficacy of isoflavones plus lactobacilli, associated or not with a natural anxiolytic agent in menopause. Minerva Ginecol. 2011; 63: 1-7
    PubMedGoogle Scholar